Business Context and Reporting Period
This Form 8-K filing by Delcath Systems, Inc. (DCTH) is dated July 8, 2024. The report addresses a corporate governance matter regarding the company's continued listing status on The Nasdaq Capital Market.
Financial Metrics
This filing does not contain financial data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is the resolution of a compliance deficiency with Nasdaq Listing Rule 5605. On May 29, 2024, the company was notified that its Audit Committee lacked the required three independent directors. On July 2, 2024, the Board appointed Dr. Bridget Martell to the Audit Committee, satisfying the independence requirement. Consequently, on July 8, 2024, Nasdaq confirmed the company had regained compliance.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business operations. The primary risk addressed was the potential delisting due to audit committee composition, which has been mitigated by the appointment of Dr. Martell. No other contingencies or unusual items are disclosed.
Key Facts for Investor Verification
- Delcath Systems, Inc. has regained compliance with Nasdaq Listing Rule 5605 regarding Audit Committee independence.
- Dr. Bridget Martell was appointed to the Audit Committee on July 2, 2024.
- The company remains listed on The Nasdaq Capital Market under the symbol DCTH.
- This filing contains no financial performance data or forward-looking financial guidance.